Drugwonks is not in favor of either. But did anyone ask real questions as in "price limits like those in Europe, Australia, Canada or the VA that limit the access of new medicines to millions of patients and delays access by 3-5 years." Or what if the "cost-effectiveness criteria used to negotiate prices meant that new drugs that delay progression of Alzheimer's by five years were never developed costing our nation $10 trillion causing 2 million additional cases of the disease that might not have occured?"
Maybe a new poll is needed. One that reflects that public policy, like all of life, is a series of tradeoffs.